SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-070127
Filing Date
2022-11-08
Accepted
2022-11-08 16:10:24
Documents
14
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea168208-8k_optimizerx.htm   iXBRL 8-K 26329
2 PRESS RELEASE, DATED NOVEMBER 8, 2022 ea168208ex99-1_optimizerx.htm EX-99.1 120554
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4361
  Complete submission text file 0001213900-22-070127.txt   339286

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE oprx-20221108.xsd EX-101.SCH 3233
5 XBRL LABEL FILE oprx-20221108_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE oprx-20221108_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT ea168208-8k_optimizerx_htm.xml XML 3595
Mailing Address 400 WATER ST., STE. 200 ROCHESTER MI 48307
Business Address 400 WATER ST., STE. 200 ROCHESTER MI 48307 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 221368964
SIC: 7389 Services-Business Services, NEC